Benzinga | Nov 6, 2020 07:13AM EST

BMO Capital Maintains Market Perform on Madrigal Pharmaceuticals, Raises Price Target to $124

BMO Capital maintains Madrigal Pharmaceuticals (NASDAQ:MDGL) with a Market Perform and raises the price target from $119 to $124.